Pet Health News Elanco Animal Health 2q Net Loss Narrowed On Higher Revenue

Elanco Animal Health Reports Second Quarter 2025 Results

Organic CC Growth = Represents revenue growth excluding the impacts from our prior year divestiture of the aqua business, which was divested July 9, 2024, royalty revenue that was sold to a third ... Read More

Elanco Animal Health Soars Past 52-Week High On Strong Sales, Raised Annual Outlook

Elanco Animal Health Incorporated (NYSE:ELAN) reported second-quarter 2025 results on Thursday, posting adjusted earnings per share of 26 cents, down 13% year over year. Despite the decline, earnings ... Read More

Elanco raises 2025 innovation revenue outlook to $720M–$800M, signals margin expansion through new launches

CEO Jeffrey N. Simmons highlighted, "Elanco continues to deliver, growing 8% organic constant currency in the quarter and exceeding the high end of guidance for revenue, adjusted EBITDA and adjusted ... Read More

Elanco Animal Health Stock Is Undervalued: Analyst

KeyBanc initiates Elanco with an Overweight rating, citing strong Innovation Product growth, margin gains, and a path to lower leverage. Read More

Curious about Elanco Animal Health (ELAN) Q2 Performance? Explore Wall Street Estimates for Key Metrics

In its upcoming report, Elanco Animal Health Incorporated (ELAN) is predicted by Wall Street analysts to post quarterly earnings of $0.20 per share, reflecting a decline of 33.3% compared to the same ... Read More

Elanco Swings to Loss, But Boosts Adjusted Earnings View on Strong Sales

Elanco Animal Health swung to a third-quarter loss as marketing and administrative expenses offset strong pet-medicine sales, but the company boosted its projection for 2025 adjusted earnings. The ... Read More

Elanco Animal Health Incorporated (ELAN) Q2 Earnings and Revenues Beat Estimates

Elanco Animal Health Incorporated (ELAN) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.2 per share. This compares to earnings of $0.3 per share a year ... Read More

Elanco raises 2025 guidance to 6%–6.5% organic growth and $840M–$880M innovation revenue following strong Q3

Earnings Call Insights: Elanco Animal Health Incorporated (ELAN) Q3 2025 Management raised full-year guidance, now expecting organic constant currency revenue growth of 6% to 6.5%, reported revenue ... Read More

Elanco wins Overweight rating, Zoetis Sector Weight as KeyBanc reviews animal health space

Shares of Elanco Animal Health (ELAN) and Zoetis (ZTS) traded higher on Friday after KeyBanc Capital Markets initiated the rival veterinary product makers with Overweight and Sector Weight ratings, ... Read More

Elanco CEO says new products helping to turn the corner on growth

Elanco Animal Health last week released what CEO Jeff Simmons called its best quarterly earnings since its 2018 spinoff from Eli Lilly and Co. Investors are now rewarding the company with a rising ... Read More